
Beijing Tong Ren Tang Chinese Medicine Company Limited
BJTRFOTCHealthcare● Active
$0.64
$-0.01(-1.26%)
Market Cap$535911420
P/E Ratio—
52W High$0.6484
52W Low$0.6402
Beijing Tong Ren Tang Chinese Medicine Company Limited(BJTRF)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · BJTRF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.51B | $12.52B | $1.53B | $1.73B | $1.56B |
| Cost of Revenue | $0.59B | $0.55B | $0.48B | $0.64B | $0.44B |
| Gross Profit | $0.93B | $1.07B | $1.05B | $1.15B | $1.11B |
| Gross Margin %(computed) | 61.16% | 8.51% | 68.67% | 66.52% | 71.43% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.19B | $1.40B | $1.21B | $1.21B |
| Total Operating Expenses | $0.45B | $0.49B | $0.42B | $0.34B | $0.34B |
| Operating Income | $0.47B | $0.57B | $0.62B | $0.81B | $0.77B |
| Operating Margin %(computed) | 31.29% | 4.58% | 40.93% | 46.92% | 49.51% |
| Interest Income | $0.05B | $0.06B | $0.57B | $0.02B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.05B | $0.00B | $0.00B |
| Income Before Tax | $0.50B | $0.63B | $0.69B | $0.83B | $0.78B |
| Income Tax Expense | $0.09B | $0.10B | $0.10B | $0.13B | $0.13B |
| Net Income | $0.40B | $0.50B | $4.22B | $0.65B | $0.61B |
| Net Margin %(computed) | 26.25% | 3.99% | 276.71% | 37.31% | 39.06% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.47 | $4.66 | $0.65 | $0.77 | $0.73 |
| Wtd Avg Shares | 0.84B | 0.84B | 0.84B | 0.84B | 0.84B |
| EBITDA | $0.57B | $0.72B | $0.64B | $0.88B | $0.79B |
| EBITDA Margin %(computed) | 37.79% | 5.77% | 42.01% | 50.69% | 50.55% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · HKD · B
深入了解Beijing Tong Ren Tang Chinese Medicine Company Limited
关于Beijing Tong Ren Tang Chinese Medicine Company Limited(BJTRF)损益表
Beijing Tong Ren Tang Chinese Medicine Company Limited(BJTRF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BJTRF实现营收$1.51B,毛利润$0.93B(毛利率61.16%),净利润$0.40B(净利率26.25%)。
常见问题
BJTRF · 4 问Beijing Tong Ren Tang Chinese Medicine Company Limited(BJTRF)2025财年营收为$1.51B,同比down87.9%。
BJTRF revenueBJTRF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09